Expect continued selling pressure as the market prices in severe dilution. The warrants' alternate cashless exercise (9x leverage) creates a strong incentive for holders to convert immediately, adding overhang. Monitor for further capital raises or Nasdaq compliance issues given the company's low market cap.
Price Chart
Executive Summary
China SXT Pharmaceuticals raised $3.5M through a dilutive private placement of 3.5M shares and 3.5M warrants at $1.00 per unit, with warrants convertible via an alternate cashless exercise at 9x beginning May 9. The offering closed May 2, 2026, and follows a similar $760K placement 25 days ago, signaling acute cash needs. Massive potential dilution (up to ~100% of current float) weighs heavily on the stock.
Key Facts
- Gross proceeds of $3.5 million from 3,500,000 Class A ordinary shares and 3,500,000 warrants
- Warrant exercise price is $1.00 per share, exercisable for 5 years
- Alternate cashless exercise allows holders to receive 9x the underlying shares starting 7 days after issuance
- Offering closed May 2, 2026; company market cap is approximately $6 million
- Second dilutive capital raise in 25 days (prior $760K placement at $0.38 on April 9)
Financial Impact
$3.5 million gross proceeds, but potential dilution of up to 7 million shares (current float estimated ~3 million) could reduce per-share value by over 50%
Risk Factors
- Further dilution from warrant exercise could depress the stock price further
- Nasdaq minimum bid price or market value of public float requirements may be breached
- Recurring capital raises indicate potential insolvency or going concern risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-051679 |
| Document: ea028894201ex4-1.htm | 0001213900-26-051679 |
| Document: ea0288942-6k_chinasxt.htm | 0001213900-26-051679 |
| Document: 0001213900-26-051679-index-headers.html | 0001213900-26-051679 |
| Document: 0001213900-26-051679-index.html | 0001213900-26-051679 |
| Document: 0001213900-26-051679.txt | 0001213900-26-051679 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | 6-K | $0.0480 | awaiting T+5 | — | — |
Oct 15, 2026 10d ago | SC 13G | $0.0650 $0.0410 | ▼ −36.92% | ▼ −36.49% | — |
Oct 9, 2026 16d ago | 6-K | $0.1020 $0.1112 | ▼ −9.02% | ▼ −10.51% | — |
Oct 9, 2026 17d ago | 424B5 | $0.1487 $0.0650 | ▲ +56.29% | ▲ +54.32% | — |
Oct 8, 2026 18d ago | 6-K | $0.3435 $0.0688 | ▲ +79.97% | ▲ +79.69% | — |
Oct 8, 2026 18d ago | 6-K | $0.3435 $0.0688 | ▲ +79.97% | ▲ +79.69% | — |
Sep 17, 2026 5w ago | EFFECT | $2.44 $2.55 | ▼ −4.72% | ▼ −4.12% | — |
Aug 28, 2026 8w ago | 6-K | $2.56 $2.24 | ▲ +12.50% | ▲ +12.36% | — |
Jul 24, 2026 13w ago | 424B5 | $0.0638 $0.0618 | ▲ +3.13% | ▲ +4.23% | — |
Jun 1, 2026 20w ago | 424B5 | $1.78 $1.56 | ▲ +12.36% | ▲ +9.39% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers